Keyphrases
Relapsed or Refractory
100%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
100%
Hodgkin Disease
100%
Complete Remission
50%
Overall Survival
33%
Day Range
33%
Transplant-related Mortality
33%
Median Time
16%
Chemotherapy
16%
Platelets
16%
Active Disease
16%
Long-term Efficacy
16%
Remission Rate
16%
Prior Treatment
16%
Dose-ranging
16%
CD34+ Cells
16%
Intensive Chemotherapy
16%
Post-transplant Period
16%
Filgrastim
16%
Partial Remission
16%
Myeloablative
16%
Transplantation Autologous
16%
Hematopoietic Recovery
16%
Myelosuppressive Chemotherapy
16%
Transfusion Support
16%
Platelet Dose
16%
Transfusion Efficacy
16%
RBC Concentrate
16%
Pharmacology, Toxicology and Pharmaceutical Science
Remission
100%
Hodgkin Disease
100%
Chemotherapy
60%
Overall Survival
40%
Disease
20%
Filgrastim
20%
Immunology and Microbiology
Autologous Stem Cell Transplantation
100%
Overall Survival
33%
Platelet
33%
CD34
16%
Leukocyte
16%
Erythrocyte
16%
Filgrastim
16%
Biochemistry, Genetics and Molecular Biology
Autologous Stem Cell Transplantation
100%
Overall Survival
33%
Platelet
33%
Leukocyte
16%
CD34
16%
Filgrastim
16%
Veterinary Science and Veterinary Medicine
Stem Cell
100%
Platelet
33%
Leukocyte
16%
Filgrastim
16%